• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

p25/Cdk5对HDAC1的去调控作用与神经毒性

Deregulation of HDAC1 by p25/Cdk5 in neurotoxicity.

作者信息

Kim Dohoon, Frank Christopher L, Dobbin Matthew M, Tsunemoto Rachel K, Tu Weihong, Peng Peter L, Guan Ji-Song, Lee Byung-Hoon, Moy Lily Y, Giusti Paola, Broodie Nisha, Mazitschek Ralph, Delalle Ivanna, Haggarty Stephen J, Neve Rachael L, Lu Youming, Tsai Li-Huei

机构信息

Howard Hughes Medical Institute, Picower Institute for Learning and Memory, Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.

出版信息

Neuron. 2008 Dec 10;60(5):803-17. doi: 10.1016/j.neuron.2008.10.015.

DOI:10.1016/j.neuron.2008.10.015
PMID:19081376
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2912147/
Abstract

Aberrant cell-cycle activity and DNA damage are emerging as important pathological components in various neurodegenerative conditions. However, their underlying mechanisms are poorly understood. Here, we show that deregulation of histone deacetylase 1 (HDAC1) activity by p25/Cdk5 induces aberrant cell-cycle activity and double-strand DNA breaks leading to neurotoxicity. In a transgenic model for neurodegeneration, p25/Cdk5 activity elicited cell-cycle activity and double-strand DNA breaks that preceded neuronal death. Inhibition of HDAC1 activity by p25/Cdk5 was identified as an underlying mechanism for these events, and HDAC1 gain of function provided potent protection against DNA damage and neurotoxicity in cultured neurons and an in vivo model for ischemia. Our findings outline a pathological signaling pathway illustrating the importance of maintaining HDAC1 activity in the adult neuron. This pathway constitutes a molecular link between aberrant cell-cycle activity and DNA damage and is a potential target for therapeutics against diseases and conditions involving neuronal death.

摘要

异常的细胞周期活动和DNA损伤正成为各种神经退行性疾病中的重要病理组成部分。然而,其潜在机制尚不清楚。在这里,我们表明,p25/Cdk5对组蛋白脱乙酰酶1(HDAC1)活性的失调会诱导异常的细胞周期活动和双链DNA断裂,从而导致神经毒性。在神经退行性疾病的转基因模型中,p25/Cdk5活性引发了在神经元死亡之前的细胞周期活动和双链DNA断裂。p25/Cdk5对HDAC1活性的抑制被确定为这些事件的潜在机制,并且HDAC1功能获得为培养的神经元和缺血体内模型中的DNA损伤和神经毒性提供了有效的保护。我们的研究结果概述了一条病理信号通路,阐明了在成年神经元中维持HDAC1活性的重要性。这条通路构成了异常细胞周期活动与DNA损伤之间的分子联系,并且是针对涉及神经元死亡的疾病和病症的治疗的潜在靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f041/2912147/c5680bcfe578/nihms84025f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f041/2912147/c220055cb2b1/nihms84025f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f041/2912147/5994c9d0761b/nihms84025f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f041/2912147/5d9c08d1ef20/nihms84025f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f041/2912147/da77c9bfd2fd/nihms84025f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f041/2912147/fc518f4536ed/nihms84025f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f041/2912147/1ecdabfccc56/nihms84025f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f041/2912147/c5680bcfe578/nihms84025f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f041/2912147/c220055cb2b1/nihms84025f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f041/2912147/5994c9d0761b/nihms84025f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f041/2912147/5d9c08d1ef20/nihms84025f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f041/2912147/da77c9bfd2fd/nihms84025f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f041/2912147/fc518f4536ed/nihms84025f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f041/2912147/1ecdabfccc56/nihms84025f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f041/2912147/c5680bcfe578/nihms84025f7.jpg

相似文献

1
Deregulation of HDAC1 by p25/Cdk5 in neurotoxicity.p25/Cdk5对HDAC1的去调控作用与神经毒性
Neuron. 2008 Dec 10;60(5):803-17. doi: 10.1016/j.neuron.2008.10.015.
2
Histone deacetylase-1 (HDAC1) is a molecular switch between neuronal survival and death.组蛋白去乙酰化酶-1(HDAC1)是神经元存活和死亡之间的分子开关。
J Biol Chem. 2012 Oct 12;287(42):35444-35453. doi: 10.1074/jbc.M112.394544. Epub 2012 Aug 23.
3
Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles.p25异常激活Cdk5会引发导致神经退行性变和神经原纤维缠结的病理事件。
Neuron. 2003 Oct 30;40(3):471-83. doi: 10.1016/s0896-6273(03)00627-5.
4
Cdk5/p25-induced cytosolic PLA2-mediated lysophosphatidylcholine production regulates neuroinflammation and triggers neurodegeneration.Cdk5/p25 诱导的细胞质 PLA2 介导的溶血磷脂酰胆碱产生调节神经炎症并引发神经退行性变。
J Neurosci. 2012 Jan 18;32(3):1020-34. doi: 10.1523/JNEUROSCI.5177-11.2012.
5
Roles of Id1/HIF-1 and CDK5/HIF-1 in cell cycle reentry induced by amyloid-beta peptide in post-mitotic cortical neuron.淀粉样β肽诱导有丝分裂后皮质神经元细胞周期再进入时 Id1/HIF-1 和 CDK5/HIF-1 的作用。
Biochim Biophys Acta Mol Cell Res. 2020 Apr;1867(4):118628. doi: 10.1016/j.bbamcr.2019.118628. Epub 2019 Dec 26.
6
Dopaminergic and glutamatergic signaling crosstalk in Huntington's disease neurodegeneration: the role of p25/cyclin-dependent kinase 5.亨廷顿舞蹈病神经变性中多巴胺能与谷氨酸能信号转导的相互作用:p25/细胞周期蛋白依赖性激酶5的作用
J Neurosci. 2008 Oct 1;28(40):10090-101. doi: 10.1523/JNEUROSCI.3237-08.2008.
7
Specific inhibition of p25/Cdk5 activity by the Cdk5 inhibitory peptide reduces neurodegeneration in vivo.特异性抑制 p25/Cdk5 活性的 Cdk5 抑制肽可减少体内神经退行性变。
J Neurosci. 2013 Jan 2;33(1):334-43. doi: 10.1523/JNEUROSCI.3593-12.2013.
8
Differential roles of nuclear and cytoplasmic cyclin-dependent kinase 5 in apoptotic and excitotoxic neuronal death.细胞核和细胞质中细胞周期蛋白依赖性激酶5在凋亡性和兴奋性毒性神经元死亡中的不同作用。
J Neurosci. 2005 Sep 28;25(39):8954-66. doi: 10.1523/JNEUROSCI.2899-05.2005.
9
A sequel to the tale of p25/Cdk5 in neurodegeneration.神经退行性变中p25/Cdk5故事的续篇。
Neuron. 2008 Dec 10;60(5):731-2. doi: 10.1016/j.neuron.2008.11.020.
10
Cdk5 acts as a mediator of neuronal cell cycle re-entry triggered by amyloid-beta and prion peptides.细胞周期蛋白依赖性激酶5(Cdk5)作为由β-淀粉样蛋白和朊病毒肽引发的神经元细胞周期重新进入的介质。
Cell Cycle. 2009 Jan 1;8(1):97-104. doi: 10.4161/cc.8.1.7506.

引用本文的文献

1
HDACs in the Brain: From Chromatin Remodeling to Neurodegenerative Disease.大脑中的组蛋白去乙酰化酶:从染色质重塑到神经退行性疾病
Cells. 2025 Aug 29;14(17):1338. doi: 10.3390/cells14171338.
2
Integrative network toxicology and molecular docking reveal 4-Nonylphenol's multifaceted mechanisms in breast cancer pathogenesis.整合网络毒理学和分子对接揭示4-壬基酚在乳腺癌发病机制中的多方面作用机制。
PLoS One. 2025 Sep 9;20(9):e0331944. doi: 10.1371/journal.pone.0331944. eCollection 2025.
3
Epigenetic Regulation in Ischemic Neuroprotection: The Dual Role of HDACs and HATs in Neuroinflammation and Recovery.缺血性神经保护中的表观遗传调控:组蛋白去乙酰化酶和组蛋白乙酰转移酶在神经炎症和恢复中的双重作用
Antioxidants (Basel). 2025 Aug 19;14(8):1015. doi: 10.3390/antiox14081015.
4
The advances in acetylation modification in senescence and aging-related diseases.衰老及衰老相关疾病中乙酰化修饰的研究进展
Front Physiol. 2025 May 12;16:1553646. doi: 10.3389/fphys.2025.1553646. eCollection 2025.
5
Protein kinases in neurodegenerative diseases: current understandings and implications for drug discovery.神经退行性疾病中的蛋白激酶:当前认识及对药物研发的意义
Signal Transduct Target Ther. 2025 May 7;10(1):146. doi: 10.1038/s41392-025-02179-x.
6
HDAC3 as an Emerging Therapeutic Target for Alzheimer's Disease and other Neurological Disorders.组蛋白去乙酰化酶3作为阿尔茨海默病和其他神经疾病的新兴治疗靶点。
Mol Neurobiol. 2025 Mar 24. doi: 10.1007/s12035-025-04866-w.
7
Contilisant-Belinostat Hybrids: Polyfunctionalized Indole Derivatives as Multineurotarget Drugs for the Potential Treatment of Alzheimer's Disease.Contilisant-贝利司他杂合物:作为潜在治疗阿尔茨海默病的多神经靶点药物的多官能化吲哚衍生物
ACS Pharmacol Transl Sci. 2025 Feb 7;8(3):831-840. doi: 10.1021/acsptsci.4c00709. eCollection 2025 Mar 14.
8
The night's watch: Exploring how sleep protects against neurodegeneration.夜间守望:探索睡眠如何预防神经退行性变。
Neuron. 2025 Mar 19;113(6):817-837. doi: 10.1016/j.neuron.2025.02.004. Epub 2025 Mar 6.
9
DNA damage and its links to neuronal aging and degeneration.DNA损伤及其与神经元衰老和退化的联系。
Neuron. 2025 Jan 8;113(1):7-28. doi: 10.1016/j.neuron.2024.12.001.
10
Role of histone deacetylase inhibitors in non-neoplastic diseases.组蛋白去乙酰化酶抑制剂在非肿瘤性疾病中的作用。
Heliyon. 2024 Jul 2;10(13):e33997. doi: 10.1016/j.heliyon.2024.e33997. eCollection 2024 Jul 15.

本文引用的文献

1
SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis.SIRT1 去乙酰化酶在阿尔茨海默病和肌萎缩侧索硬化症模型中可预防神经退行性变。
EMBO J. 2007 Jul 11;26(13):3169-79. doi: 10.1038/sj.emboj.7601758. Epub 2007 Jun 21.
2
Histone deacetylase inhibitors enhance memory and synaptic plasticity via CREB:CBP-dependent transcriptional activation.组蛋白去乙酰化酶抑制剂通过CREB:CBP依赖的转录激活增强记忆和突触可塑性。
J Neurosci. 2007 Jun 6;27(23):6128-40. doi: 10.1523/JNEUROSCI.0296-07.2007.
3
Expression of cyclin-dependent kinase 5 mRNA and protein in the human brain following acute ischemic stroke.急性缺血性脑卒中后人脑细胞周期蛋白依赖性激酶5 mRNA和蛋白的表达
Brain Pathol. 2007 Jan;17(1):11-23. doi: 10.1111/j.1750-3639.2006.00031.x.
4
Recovery of learning and memory is associated with chromatin remodelling.学习和记忆的恢复与染色质重塑有关。
Nature. 2007 May 10;447(7141):178-82. doi: 10.1038/nature05772. Epub 2007 Apr 29.
5
Cell cycle machinery and stroke.细胞周期机制与中风
Biochim Biophys Acta. 2007 Apr;1772(4):484-93. doi: 10.1016/j.bbadis.2006.11.009. Epub 2006 Dec 5.
6
Phase 1 and pharmacologic study of MS-275, a histone deacetylase inhibitor, in adults with refractory and relapsed acute leukemias.组蛋白去乙酰化酶抑制剂MS-275在难治性和复发性急性白血病成人患者中的1期和药理学研究。
Blood. 2007 Apr 1;109(7):2781-90. doi: 10.1182/blood-2006-05-021873.
7
Cdk5 is involved in NFT-like tauopathy induced by transient cerebral ischemia in female rats.细胞周期蛋白依赖性激酶5(Cdk5)参与雌性大鼠短暂性脑缺血诱导的类神经纤维缠结的tau蛋白病。
Biochim Biophys Acta. 2007 Apr;1772(4):473-83. doi: 10.1016/j.bbadis.2006.10.011. Epub 2006 Oct 18.
8
Calpain-induced proteolysis after transient global cerebral ischemia and ischemic tolerance in a rat model.短暂性全脑缺血后钙蛋白酶诱导的蛋白水解作用及大鼠模型中的缺血耐受性
Neurochem Res. 2006 Dec;31(12):1433-41. doi: 10.1007/s11064-006-9195-7. Epub 2006 Nov 7.
9
Histone deacetylation as a target for radiosensitization.组蛋白去乙酰化作为放射增敏的靶点
Curr Top Dev Biol. 2006;73:173-204. doi: 10.1016/S0070-2153(05)73006-4.
10
Neuroprotection by histone deacetylase-related protein.组蛋白去乙酰化酶相关蛋白的神经保护作用。
Mol Cell Biol. 2006 May;26(9):3550-64. doi: 10.1128/MCB.26.9.3550-3564.2006.